Cargando…
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation
RNA splicing factor SF3B1 is recurrently mutated in various cancers, particularly in hematologic malignancies. We previously reported that coexpression of Sf3b1 mutation and Atm deletion in B cells, but not either lesion alone, leads to the onset of chronic lymphocytic leukemia (CLL) with CLL cells...
Autores principales: | Cusan, Martina, Shen, Haifeng, Zhang, Bo, Liao, Aijun, Yang, Lu, Jin, Meiling, Fernandez, Mike, Iyer, Prajish, Wu, Yiming, Hart, Kevyn, Gutierrez, Catherine, Nik, Sara, Pruett-Miller, Shondra M., Stark, Jeremy, Obeng, Esther A., Bowman, Teresa V., Wu, Catherine J., Lin, Ren-Jang, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471171/ https://www.ncbi.nlm.nih.gov/pubmed/37463047 http://dx.doi.org/10.1172/JCI163325 |
Ejemplares similares
-
The process of leukemogenesis.
por: Irons, R D, et al.
Publicado: (1996) -
The Philadelphia chromosome in leukemogenesis
por: Kang, Zhi-Jie, et al.
Publicado: (2016) -
Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns
por: Tang, Alison D., et al.
Publicado: (2020) -
Emerging Therapies in CLL in the Era of Precision Medicine
por: Iyer, Prajish, et al.
Publicado: (2023) -
Leukemogenesis and ageing: ‘fit for transformation’ ?
por: Greaves, Mel
Publicado: (2011)